Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 9 studies | 21% ± 4% | |
| epithelial cell | 6 studies | 39% ± 20% | |
| interneuron | 6 studies | 23% ± 6% | |
| glutamatergic neuron | 5 studies | 28% ± 6% | |
| endothelial cell | 5 studies | 28% ± 7% | |
| GABAergic neuron | 5 studies | 24% ± 11% | |
| squamous epithelial cell | 4 studies | 43% ± 12% | |
| macrophage | 4 studies | 18% ± 5% | |
| OFF-bipolar cell | 4 studies | 36% ± 9% | |
| basal cell | 4 studies | 20% ± 3% | |
| retinal rod cell | 4 studies | 18% ± 1% | |
| classical monocyte | 3 studies | 18% ± 2% | |
| connective tissue cell | 3 studies | 21% ± 4% | |
| B cell | 3 studies | 20% ± 3% | |
| naive B cell | 3 studies | 18% ± 2% | |
| retinal bipolar neuron | 3 studies | 27% ± 3% | |
| dendritic cell | 3 studies | 27% ± 8% | |
| group 3 innate lymphoid cell | 3 studies | 28% ± 10% | |
| luminal cell of prostate epithelium | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 5545.04 | 245 / 245 | 100% | 82.89 | 502 / 502 |
| breast | 100% | 5498.39 | 458 / 459 | 99% | 66.44 | 1110 / 1118 |
| thymus | 100% | 2773.64 | 651 / 653 | 99% | 33.16 | 596 / 605 |
| kidney | 100% | 3392.07 | 89 / 89 | 97% | 35.79 | 876 / 901 |
| brain | 99% | 3971.31 | 2618 / 2642 | 97% | 19.86 | 684 / 705 |
| bladder | 100% | 3514.90 | 21 / 21 | 95% | 30.96 | 481 / 504 |
| lung | 99% | 2636.52 | 573 / 578 | 96% | 22.09 | 1109 / 1155 |
| ovary | 99% | 2444.22 | 179 / 180 | 94% | 19.53 | 406 / 430 |
| esophagus | 100% | 4641.95 | 1438 / 1445 | 93% | 19.19 | 171 / 183 |
| uterus | 100% | 3397.86 | 170 / 170 | 92% | 22.69 | 424 / 459 |
| intestine | 98% | 2379.05 | 950 / 966 | 89% | 15.11 | 467 / 527 |
| skin | 99% | 3074.63 | 1792 / 1809 | 83% | 15.18 | 392 / 472 |
| stomach | 92% | 1464.61 | 330 / 359 | 89% | 14.62 | 255 / 286 |
| adrenal gland | 91% | 1742.40 | 235 / 258 | 81% | 14.72 | 187 / 230 |
| pancreas | 70% | 834.09 | 228 / 328 | 97% | 23.98 | 173 / 178 |
| blood vessel | 100% | 4761.49 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3589.59 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 19.18 | 1 / 1 |
| adipose | 99% | 3968.44 | 1196 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 18.57 | 42 / 45 |
| peripheral blood | 88% | 2249.03 | 814 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 86% | 19.56 | 25 / 29 |
| muscle | 64% | 829.19 | 515 / 803 | 0% | 0 | 0 / 0 |
| heart | 61% | 745.86 | 522 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 53% | 6.64 | 42 / 80 |
| liver | 27% | 236.40 | 61 / 226 | 23% | 3.30 | 95 / 406 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000079 | Biological process | regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO_0051301 | Biological process | cell division |
| GO_0051726 | Biological process | regulation of cell cycle |
| GO_0044772 | Biological process | mitotic cell cycle phase transition |
| GO_0000307 | Cellular component | cyclin-dependent protein kinase holoenzyme complex |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0016538 | Molecular function | cyclin-dependent protein serine/threonine kinase regulator activity |
| Gene name | CCNG2 |
| Protein name | Cyclin-G2 Cyclin G2 |
| Synonyms | |
| Description | FUNCTION: May play a role in growth regulation and in negative regulation of cell cycle progression. |
| Accessions | ENST00000395640.5 [Q16589-1] ENST00000512918.5 D6RHI3 ENST00000509972.1 [Q16589-2] ENST00000316355.10 [Q16589-1] Q16589 ENST00000502280.5 [Q16589-1] |